Classification of Japanese OTC drugs [BR:br08313]
Agents for integumentary system
57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
D02264 Dipotassium glycyrrhizinate (JAN)
Agents for ophthalmologic use
62 General eye drops
D02264 Dipotassium glycyrrhizinate (JAN)
67 Eyewash
D02264 Dipotassium glycyrrhizinate (JAN)
Agents for otolaryngologic use
69 Oral medicine for nasal inflammation
D02264 Dipotassium glycyrrhizinate (JAN)
Agents for dental and stomatological use
73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)
D02264 Dipotassium glycyrrhizinate (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Glycyrrhizin
D02264 Dipotassium glycyrrhizinate (JAN)
Animal drugs in Japan [BR:br08331]
95 Agents for external use
956 Bath and disinfectants preparations
9562 Disinfectants preparations
C14049 Glycyrrhizinate dipotassium
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D02264 Dipotassium glycyrrhizinate
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D02264 Dipotassium glycyrrhizinate
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
HSD11B1
D02264 Dipotassium glycyrrhizinate (JAN)